Ruzurgi (2021-09-09) - Recalls and safety alerts

Ruzurgi (2021-09-09) - Recalls and safety alerts
Starting date:
September 9, 2021
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-76465

Last updated:

2021-09-20
  • Product: Ruzurgi

Total combinated yeasts and molds count (TYMC) is out of specification in the affected lot.

Wholesalers, Retailers, End users.

 
DIN 02503034

Tablet 

Amifampridine 10 mg

18038

Recalling Firm
Medunik Canada 950 Michèle-Bohec Blainville J7C 5E2 Quebec CANADA

 

Marketing Authorization Holder
Medunik Canada 950 Michèle-Bohec Blainville J7C 5E2 Quebec CANADA

To read more Press Release articles, click here.